UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients

FHS
April 6, 2024
3:51 am

A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery is safe and may improve long-term outcomes.

Longer treatment gave better liver outcomes for MASH patients, Akero drug study shows

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted

March 4, 2024

5 Fascinating Insights from Top Psychedelics Researcher

If you’ve been following the psychedelics renaissance unfolding over the last two decades, you probably have heard of Dr. Matthew Johnson, a professor of psychiatry

September 6, 2023

Hot Yoga May Help With Depression

A hot yoga session at least once a week improved depressive symptoms in people with moderate-to-severe depression, researchers found. In a small randomized controlled trial,

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.